Molecular Diagnostic Testing Services – Respiratory Panel

The contract entails full operational support for respiratory pathogen panel testing using molecular systems owned and maintained by the contractor, encompassing all necessary reagents, routine maintenance, and ongoing technical assistance to ensure uninterrupted testing capacity. This subcontract is issued under the Department of Veterans Affairs through the Network Contract Office 19, with a NAICS code of 621511 indicating diagnostic laboratory services, and is intended to provide reliable, high-throughput molecular diagnostics for respiratory pathogens across VA facilities. The contractor is responsible for end-to-end performance, including system uptime, quality control, and rapid response to technical issues, ensuring clinical accuracy and compliance with healthcare standards without reliance on government-provided equipment or reagents. The opportunity was posted on May 1, 2026, with responses due by June 8, 2026, at 4:00 p.m., offering a structured window for qualified providers to submit proposals. There is no specified set-aside designation, meaning the contract is open to all eligible entities regardless of small business status or other classifications. The place of performance and point of contact details are not provided, suggesting that services may be delivered remotely or at multiple VA locations as needed. This contractual arrangement emphasizes performance-based outcomes, requiring the contractor to maintain consistent, high-quality diagnostic capabilities to support Veterans’ health outcomes through timely and accurate pathogen identification.